Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Int J Food Microbiol ; 312: 108362, 2020 Jan 02.
Article in English | MEDLINE | ID: mdl-31669764

ABSTRACT

Stuck and sluggish fermentations are among the main problems in winemaking industry leading to important economic losses. Several factors have been described as causes of stuck and sluggish fermentations, being exposure to extreme temperatures barely studied. The objective of this study was to identify thermal conditions leading to stuck and sluggish fermentations, focusing on the impact of an abrupt and transient decrease/increase of temperature on fermentation performance and yeast viability/vitality. Different strains of Saccharomyces cerevisiae, SBB11, T73, and PDM were evaluated in synthetic grape must fermentations. Cold shocks (9 °C and 1.5 °C for 16 h) carried out on different days during the fermentation process were unable to alter fermentation performance. Conversely, shock temperatures higher than 32 °C, applied in early stages of the process, lead to sluggish fermentation showing a delay directly related to the temperature increase. Fermentation delay was associated with a decrease in cell vitality. The impact of the heat shock on fermentation performance was different depending on the strain evaluated and nitrogen supplementation (with or without diammonium phosphate addition). None of the conditions evaluated produced a stuck fermentation and importantly, in all cases must nutrition improved fermentation performance after a heat shock.


Subject(s)
Cold Temperature , Fermentation/physiology , Hot Temperature , Saccharomyces cerevisiae/metabolism , Cold-Shock Response/physiology , Heat-Shock Response/physiology , Phosphates/pharmacology , Vitis/metabolism , Wine/analysis
2.
Rev. bras. plantas med ; Rev. bras. plantas med;17(4,supl.2): 915-921, 2015. tab, graf
Article in Portuguese | LILACS | ID: lil-771162

ABSTRACT

RESUMO Agentes químicos têm sido usados para auxiliar na inibição da formação do biofilme e impedir desenvolvimento da doença periodontal (DP). O objetivo deste estudo foi avaliar radiograficamente a ação do extrato de própolis na progressão da DP induzida em ratos. Foram utilizados 48 ratos Wistar, divididos em 4 grupos (n=12): Controle, Pincel, Própolis e Clorexidina. Os grupos foram subdivididos para análise aos 7 e 21 dias. A progressão da DP foi avaliada radiograficamente pela distância entre a junção cemento-esmalte e a crista óssea alveolar na face mesial do 1º molar inferior. A perda óssea foi significativamente menor nos animais do grupo própolis em ambos os períodos (p ≤ 0,01). Concluiu-se por análise radiográfica que a aplicação tópica do extrato de própolis interfere reduzindo a progressão da doença periodontal induzida por ligadura em ratos, demonstrando a importância desse composto como substância auxiliar no tratamento periodontal.


ABSTRACT Chemical agents have been used to assist on inhibiting biofilm formation and on preventing the development of periodontal disease (PD). The aim of this study was to radiographically evaluate the action of propolis extract on the progression of PD induced in rats. 48 Wistar rats were divided into 4 groups (n = 12): Control, Brush, Propolis and Chlorhexidine. The groups were subdivided for analysis at 7 and 21 days. The progression of the periodontal disease was radiographically assessed by the distance between the cement-enamel junction and the alveolar bone crest mesial of the 1st molar. Bone loss was significantly lower in the Propolis group in both periods (p ≤ 0.01). By radiographic analysis, it is concluded that the topical application of propolis extract interferes by reducing the progression of ligature-induced periodontal disease in rats, demonstrating the importance of this compound as an auxiliary substance in periodontal treatment.


Subject(s)
Rats , Periodontal Diseases/prevention & control , Propolis/analysis , Periodontics/classification , Disease Progression , Diagnostic Imaging
3.
J Inherit Metab Dis ; 31(6): 724-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18925426

ABSTRACT

BACKGROUND: Treatment with oral creatine monohydrate has not shown efficacy in patients with creatine transporter deficiency (CRTR-D). Another therapeutic option proposed is L-arginine, the substrate for the enzyme L-arginine:glycine amidinotransferase (AGAT). We evaluate clinical characteristics and cerebral creatine replenishment after L-arginine therapy in four patients with CRTR-D. PATIENTS AND METHODS: Four boys with genetically confirmed diagnosis of CRTR-D (ages 9-16 years) were supplemented with L-arginine (0.4 g/kg per day) for a period of 9 months. Treatment efficacy was evaluated by clinical and neuropsychological assessment and determination of creatine signals by brain proton magnetic resonance spectroscopy ((1)H-MRS). RESULTS: Epileptic seizures remained well controlled with antiepileptic drugs in three cases, both before and after L-arginine supplementation. Vineland Adaptive Behaviour Scale did not show any change in communication, daily living skills, socialization or motor skills, and a lack of improvement in brain (1)H-MRS follow-up was observed. L-Arginine was discontinued at the end of the observation period. CONCLUSIONS: Nine months of L-arginine supplementation did not show effectiveness in the four patients affected with CRTR-D in this protocol.


Subject(s)
Arginine/therapeutic use , Genes, X-Linked , Membrane Transport Proteins/deficiency , Membrane Transport Proteins/genetics , Administration, Oral , Adolescent , Age of Onset , Child , Chromosomes, Human, X/genetics , Creatine/administration & dosage , Dietary Supplements , Epilepsy/drug therapy , Humans , Magnetic Resonance Spectroscopy , Male , Membrane Transport Proteins/metabolism , Metabolism, Inborn Errors/diagnosis , Metabolism, Inborn Errors/drug therapy , Metabolism, Inborn Errors/genetics
4.
An. psiquiatr ; 23(4): 199-205, jul.-ago. 2007. tab
Article in Es | IBECS | ID: ibc-62342

ABSTRACT

Introducción: En un abordaje integral de la epilepsia es indispensable considerar aquellos aspectos psicosociales que afectan a la consideración del enfermo acerca del impacto de su enfermedad. Objetivos: Determinar el estado actual de la actitud social frente a la epilepsia en la isla de Mallorca. Analizar si se han producido cambios en la actitud social frente a la epilepsia y el enfermo epiléptico en la isla de Mallorca. Sujetos: 729 residentes en la isla de Mallorca. Método: Se elaboró un cuestionario basado en el diseñado previamente por los autores, el cual permite describir tres perfiles actitudinales frente a la epilepsia: Estigmatizador, Integrador e Inconsistente. Resultados y Conclusiones: Se observa un claro predominio de la actitud integradora y una práctica ausencia de actitud estigmatizadora, aunque persiste una actitud inconsistente en aproximadamente un tercio de los encuestados. Longitudinalmente, se observa una traslación hacia actitudes más positivas


Introduction: On a holistic approach to Epilepsy is essential to consider psychosocial aspects that affects the patient´s consideration about the impact of his disease. Objectives: To assess the actual social attitude towards epilepsy in Majorca. To analyze if there have been changes in the social attitudes towards epilepsy and the epileptic patients, and if so, in what sense, comparison with a precious survey made 20 years ago. Subjects: 729 residents in Majorca. Method: We made a questionnaire based on one previously designed by the authors, that allows to describe three attitudinal profiles regarding epilepsy: stigmatizer, integrative and inconsistent. Results and Conclusions: We observed a clear predominance of an integrative attitude and a practical absence of the stigmagtizant one, but an inconsistent attitude persists in one third of the population interviewed. Longitudinally, we observed a translation tomore positive attitudes (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Epilepsy/diagnosis , Epilepsy/psychology , Surveys and Questionnaires , Self Concept , Interview, Psychological/methods , Social Support , Psychosocial Impact , Health Knowledge, Attitudes, Practice , Epilepsy/complications , Epilepsy/epidemiology
5.
Biol Trace Elem Res ; 20(1-2): 95-104, 1989.
Article in English | MEDLINE | ID: mdl-2484406

ABSTRACT

The erythrocyte-mediated reduction of selenite has been reproduced by the addition of reduced glutathione to plasma at levels comparable to those present in the erythrocyte. The reaction has been followed by chromatography and ultraviolet (UV) absorption spectroscopy (in the absence of plasma). The first detectable compound, selenium diglutathione, is very unstable in physiological conditions. The product of the reaction does not contain glutathione and is able to react and incorporate selenium into plasma proteins without the participation of hemoglobin or glutathione reductase. A saturable low molecular weight compound is also able to bind selenium, which may be relevant in the initial distribution and excretion of selenium after selenite administration.


Subject(s)
Glutathione/physiology , Selenium/blood , Blood Proteins/metabolism , Chromatography, Gel , Chromatography, Thin Layer , Erythrocytes/metabolism , Glutathione Reductase/blood , Humans , In Vitro Techniques , Selenious Acid , Selenium Radioisotopes , Spectrophotometry, Ultraviolet
6.
Biol Trace Elem Res ; 15: 97-110, 1988.
Article in English | MEDLINE | ID: mdl-2484530

ABSTRACT

The binding of selenite, the form of selenium used in the treatment of Keshan disease, to plasma proteins and the role of erythrocytes in this process have been studied. The experiments were carried out by incubating 75Se as selenite with plasma and whole blood in vitro (human and rat) and in vivo (rat) and subsequent fractionation by Sephadex G-150 gel filtration. Human and rat plasma proteins were unable to incorporate selenium from selenite, as shown by the negligible amount present in proteins after incubation of plasma with selenite. The incorporation can be carried out after internalization of selenite by the erythrocytes in a fast, temperature dependent process. Hemoglobin, being the major binding protein for the newly reduced selenium in the erythrocyte, might have a role in the uptake of selenite by erythrocytes. The greater affinity of plasma proteins for the final selenium compound resulting from reduction could be the cause of the efflux. However, this is minimal in the absence of plasma, as is evident from the results obtained from blood reconstituted with saline solution instead of plasma. At least two proteins, one albumin like, probably albumin itself and the other of molecular weight close to or greater than 200,000 in the plasma, are involved in the binding and efflux processes.


Subject(s)
Selenium/blood , Animals , Blood Proteins/metabolism , Erythrocytes/metabolism , Humans , In Vitro Techniques , Male , Rats , Rats, Inbred Strains , Selenious Acid , Selenium Radioisotopes , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL